FactSet Research Systems (FDS) Valuation Reassessed After AI Doc Ingest Launch For Cobalt Platform

Simply Wall St.

Feb 08

FactSet Research Systems (FDS) has rolled out the beta version of AI Doc Ingest for its Cobalt platform, an AI-driven tool aimed at automating portfolio company data collection for private capital ...

Source Link

Disclaimer: Investing carries risk. This is not financial advice. The above content should not be regarded as an offer, recommendation, or solicitation on acquiring or disposing of any financial products, any associated discussions, comments, or posts by author or other users should not be considered as such either. It is solely for general information purpose only, which does not consider your own investment objectives, financial situations or needs. TTM assumes no responsibility or warranty for the accuracy and completeness of the information, investors should do their own research and may seek professional advice before investing.

Most Discussed

{"basename":"","ssrTDKData":{"titleTemplate":"%s - Tiger Brokers","title":"Tiger Brokers | Global Stocks, Options & Futures Trading App","description":"Tiger Brokers, one-stop investment in US stocks, SGX stocks, HK stocks, A-shares & other global assets. One of the best stock trading platforms in Singapore.","keywords":"tiger brokers,tiger trade,tiger brokers singapore,broker online,stock trading in singapore,share trading singapore,brokerage firm singapore,trading app,stock broker singapore,stock trading platforms,trading account","social":{"ogDescription":"Tiger Brokers, one-stop investment in US stocks, SGX stocks, HK stocks, A-shares & other global assets. One of the best stock trading platforms in Singapore.","ogImage":"https://c1.itigergrowtha.com/portal5/static/media/og-logo.be62fbe1.png","ogUrl":"https://www.itiger.com/news/2609573651"},"companyName":"Tiger Brokers"},"pageData":{"isMobile":false,"isTiger":false,"isTTM":true,"region":"SGP","license":"TBSG","edition":"fundamental"},"isCrawlerRequest":true,"__swrFallback__":{"@#url:\"https://stock-news.skytigris.cn/v3/news\",params:#id:\"2609573651\",edition:\"fundamental\",auth_exemption:1,,,undefined,":{"share":"https://ttm.financial/m/news/2609573651?lang=en_US&edition=fundamental","thumbnail":"https://images.simplywall.st/asset/industry/1033402-choice2-main-header/1585186850577","is_english":true,"pubTime":"2026-02-08 11:12","share_image_url":"https://static.laohu8.com/e9f99090a1c2ed51c021029395664489","id":"2609573651","market":"sg","top_or_hot":-1,"title":"FactSet Research Systems (FDS) Valuation Reassessed After AI Doc Ingest Launch For Cobalt Platform","media":"Simply Wall St.","content":"<div>\n<p>FactSet Research Systems (FDS) has rolled out the beta version of AI Doc Ingest for its Cobalt platform, an AI-driven tool aimed at automating portfolio company data collection for private capital ...</p>\n\n<a href=\"https://simplywall.st/stocks/us/diversified-financials/nyse-fds/factset-research-systems/news/factset-research-systems-fds-valuation-reassessed-after-ai-d\">Source Link</a>\n\n</div>\n","source":"simplywall_highlight","html":"<!DOCTYPE html>\n<html>\n<head>\n<meta http-equiv=\"Content-Type\" content=\"text/html; charset=utf-8\" />\n<meta name=\"viewport\" content=\"width=device-width,initial-scale=1.0,minimum-scale=1.0,maximum-scale=1.0,user-scalable=no\"/>\n<meta name=\"format-detection\" content=\"telephone=no,email=no,address=no\" />\n<title>FactSet Research Systems (FDS) Valuation Reassessed After AI Doc Ingest Launch For Cobalt Platform</title>\n<style type=\"text/css\">\na,abbr,acronym,address,applet,article,aside,audio,b,big,blockquote,body,canvas,caption,center,cite,code,dd,del,details,dfn,div,dl,dt,\nem,embed,fieldset,figcaption,figure,footer,form,h1,h2,h3,h4,h5,h6,header,hgroup,html,i,iframe,img,ins,kbd,label,legend,li,mark,menu,nav,\nobject,ol,output,p,pre,q,ruby,s,samp,section,small,span,strike,strong,sub,summary,sup,table,tbody,td,tfoot,th,thead,time,tr,tt,u,ul,var,video{ font:inherit;margin:0;padding:0;vertical-align:baseline;border:0 }\nbody{ font-size:16px; line-height:1.5; color:#999; background:transparent; }\n.wrapper{ overflow:hidden;word-break:break-all;padding:10px; }\nh1,h2{ font-weight:normal; line-height:1.35; margin-bottom:.6em; }\nh3,h4,h5,h6{ line-height:1.35; margin-bottom:1em; }\nh1{ font-size:24px; }\nh2{ font-size:20px; }\nh3{ font-size:18px; }\nh4{ font-size:16px; }\nh5{ font-size:14px; }\nh6{ font-size:12px; }\np,ul,ol,blockquote,dl,table{ margin:1.2em 0; }\nul,ol{ margin-left:2em; }\nul{ list-style:disc; }\nol{ list-style:decimal; }\nli,li p{ margin:10px 0;}\nimg{ max-width:100%;display:block;margin:0 auto 1em; }\nblockquote{ color:#B5B2B1; border-left:3px solid #aaa; padding:1em; }\nstrong,b{font-weight:bold;}\nem,i{font-style:italic;}\ntable{ width:100%;border-collapse:collapse;border-spacing:1px;margin:1em 0;font-size:.9em; }\nth,td{ padding:5px;text-align:left;border:1px solid #aaa; }\nth{ font-weight:bold;background:#5d5d5d; }\n.symbol-link{font-weight:bold;}\n/* header{ border-bottom:1px solid #494756; } */\n.title{ margin:0 0 8px;line-height:1.3;color:#ddd; }\n.meta {color:#5e5c6d;font-size:13px;margin:0 0 .5em; }\na{text-decoration:none; color:#2a4b87;}\n.meta .head { display: inline-block; overflow: hidden}\n.head .h-thumb { width: 30px; height: 30px; margin: 0; padding: 0; border-radius: 50%; float: left;}\n.head .h-content { margin: 0; padding: 0 0 0 9px; float: left;}\n.head .h-name {font-size: 13px; color: #eee; margin: 0;}\n.head .h-time {font-size: 11px; color: #7E829C; margin: 0;line-height: 11px;}\n.small {font-size: 12.5px; display: inline-block; transform: scale(0.9); -webkit-transform: scale(0.9); transform-origin: left; -webkit-transform-origin: left;}\n.smaller {font-size: 12.5px; display: inline-block; transform: scale(0.8); -webkit-transform: scale(0.8); transform-origin: left; -webkit-transform-origin: left;}\n.bt-text {font-size: 12px;margin: 1.5em 0 0 0}\n.bt-text p {margin: 0}\n</style>\n</head>\n<body>\n<div class=\"wrapper\">\n<header>\n<h2 class=\"title\">\nFactSet Research Systems (FDS) Valuation Reassessed After AI Doc Ingest Launch For Cobalt Platform\n</h2>\n\n<h4 class=\"meta\">\n\n\n2026-02-08 11:12 GMT+8&nbsp;&nbsp;&nbsp;<a href=https://simplywall.st/stocks/us/diversified-financials/nyse-fds/factset-research-systems/news/factset-research-systems-fds-valuation-reassessed-after-ai-d><strong>Simply Wall St.</strong></a>\n\n\n</h4>\n\n</header>\n<article>\n<div>\n<p>FactSet Research Systems (FDS) has rolled out the beta version of AI Doc Ingest for its Cobalt platform, an AI-driven tool aimed at automating portfolio company data collection for private capital ...</p>\n\n<a href=\"https://simplywall.st/stocks/us/diversified-financials/nyse-fds/factset-research-systems/news/factset-research-systems-fds-valuation-reassessed-after-ai-d\">Source Link</a>\n\n</div>\n\n\n</article>\n</div>\n</body>\n</html>\n","isBrief":false,"type":0,"news_type":1,"symbol":"BK4567","symbol_name":"ESG概念","start_time":0,"source_url":"https://simplywall.st/stocks/us/diversified-financials/nyse-fds/factset-research-systems/news/factset-research-systems-fds-valuation-reassessed-after-ai-d","article_id":"2609573651","we_media_id":null,"thumbnails":["https://images.simplywall.st/asset/industry/1033402-choice2-main-header/1585186850577"],"rights":{"source":"simplywall_highlight","url":"https://simplywall.st/stocks/us/diversified-financials/nyse-fds/factset-research-systems/news/factset-research-systems-fds-valuation-reassessed-after-ai-d","rn_cache_url":null,"directOrigin":true},"url":"https://stock-news.laohu8.com/highlight/detail?id=2609573651","pubTimestamp":1770520364,"columns":[],"sourceInfo":{"source_id":"simplywall_highlight","name":"Simply Wall St."},"weMediaInfo":null,"summary":"FactSet Research Systems (FDS) has rolled out the beta version of AI Doc Ingest for its Cobalt platform, an AI-driven tool aimed at automating portfolio company data collection for private capital managers.\nSee our latest analysis for FactSet Research Systems.\nThe AI Doc Ingest launch lands at a tricky time for the stock, with the latest share price at $207.32 after a 30 day share price return of 29.59% decline and a 1 year total shareholder return of 55.07% decline. This points to fading...","collect":0,"end_time":0,"defaultTopTitle":"simplywall.st","property":[],"viewcount":null,"language":"en","relate_stocks":{"BK4567":"ESG概念","BK4585":"ETF&股票定投概念","BK4023":"应用软件","AI":"C3.ai, Inc.","BK4112":"金融交易所和数据","BK4588":"碎股","FDS":"辉盛研究系统","LU2210149790.SGD":"Natixis Thematics Subscription Economy R/A SGD-H","LU2095319765.USD":"Natixis Thematics Subscription Economy R/A USD","BK4543":"AI","BK4551":"寇图资本持仓","BK4587":"ChatGPT概念","LU2210150020.SGD":"Natixis Thematics Subscription Economy R/A SGD","BK4528":"SaaS概念"},"translate_title":"FactSet Research Systems(FDS)在Cobalt平台推出AI Doc Ingest后重新评估估值","themeId":null,"isJumpTheme":false,"ttsUrl":null,"symbols_score_info":{"AI":0.9,"FDS":1.5},"content_text":"FactSet Research Systems (FDS) has rolled out the beta version of AI Doc Ingest for its Cobalt platform, an AI-driven tool aimed at automating portfolio company data collection for private capital managers. See our latest analysis for FactSet Research Systems. The AI Doc Ingest launch lands at a tricky time for the stock, with the latest share price at $207.32 after a 30 day share price return of 29.59% decline and a 1 year total shareholder return of 55.07% decline. This points to fading momentum as investors reassess growth prospects and risk around execution. If you are looking beyond a single data and analytics name, this could be a good moment to scan 56 profitable AI stocks that aren't just burning cash as a starting list of AI focused opportunities with established businesses. With the stock down sharply and trading around 12.6x forward P/E, plus a regular quarterly dividend of $1.10 per share still in place, is this reset creating a buying opportunity, or is the market already pricing in future growth? AdvertisementMost Popular Narrative: 34% Undervalued At a last close of $207.32 against a narrative fair value of $313.99, the story around FactSet is very different from what the share price suggests, according to SelectiveCapital.  At the current price of approximately 210 USD, the market is valuing FactSet as a certain victim of generative AI (“SaaSPocalypse”), completely ignoring the company’s structural transformation over the last 5 years. FactSet no longer sells just access to stock prices (which can be commoditized); it sells operational infrastructure built on four strategic pillars that are extremely hard for a chatbot to replace: Cobalt (Private Markets), CUSIP (Global Standards), Vermilion (Reporting), and Portware (Execution).  Read the complete narrative. It is curious how a data vendor ends up priced like a cash cow, yet receives a value closer to a financial infrastructure owner. The narrative leans heavily on resilient margins, steady expansion in key workflows and a future profit multiple more often associated with premium software names. Investors may want to examine which growth and profitability assumptions would need to hold for that fair value to be supported. Result: Fair Value of $313.99 (UNDERVALUED) Have a read of the narrative in full and understand what's behind the forecasts. However, this hinges on CUSIP and Cobalt living up to high expectations, and any slowdown in client adoption or pricing power could quickly weaken that fair value story. Find out about the key risks to this FactSet Research Systems narrative.  Build Your Own FactSet Research Systems Narrative If you look at the numbers and reach a different conclusion, or simply prefer to test your own assumptions, you can build a fresh FactSet story yourself in just a few minutes by starting with Do it your way. A great starting point for your FactSet Research Systems research is our analysis highlighting 5 key rewards and 1 important warning sign that could impact your investment decision. Looking for more investment ideas? If you are serious about tightening up your portfolio, do not stop at one company story. Use the screener to surface fresh ideas before others do.  Target quality at a discount by scanning our list of 52 high quality undervalued stocks that combine solid fundamentals with prices that may not fully reflect their strengths. Strengthen your income stream by reviewing 14 dividend fortresses, focused on companies with higher yields and an emphasis on durability of payouts. Dial down portfolio risk by checking 83 resilient stocks with low risk scores, featuring businesses with profiles that may help smooth out the bumps in your overall returns.   This article by Simply Wall St is general in nature. We provide commentary based on historical data\n    and analyst forecasts only using an unbiased methodology and our articles are not intended to be financial advice. It does not constitute a recommendation to buy or sell any stock, and does not take account of your objectives, or your\n    financial situation. We aim to bring you long-term focused analysis driven by fundamental data.\n    Note that our analysis may not factor in the latest price-sensitive company announcements or qualitative material.\n    Simply Wall St has no position in any stocks mentioned.New: AI Stock Screener & AlertsOur new AI Stock Screener scans the market every day to uncover opportunities.• Dividend Powerhouses (3%+ Yield)• Undervalued Small Caps with Insider Buying• High growth Tech and AI CompaniesOr build your own from over 50 metrics.Explore Now for FreeHave feedback on this article? Concerned about the content? Get in touch with us directly. Alternatively, email editorial-team@simplywallst.com","kind":"highlight","is_publish_news":true,"is_publish_highlight":false,"is_publish_live":false,"is_publish_wemedia":null,"editions":null,"column":"","sentiment":"1","news_tag":"productRelease","news_rank":0,"symbols":[],"gpt_button":0,"need_auth":false,"code":"91000000","status":"200"}}}